http://jcps.bjmu.edu.cn

中国药学(英文版) ›› 2016, Vol. 25 ›› Issue (7): 477-488.DOI: 10.5246/jcps.2016.07.053

• 【传统中药和植物药的癌症预防专栏】 •    下一篇

Development and validation of a rapid UPLC/MS method for the simultaneous determination of I3C, DIM, and related metabolites and its application to pharmacokinetics studies

Yury Gomez1, Hu Wang1, Ah-Ng Tony Kong2*   

  1. 1. Graduate Program in Pharmaceutical Science, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854
    2. Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854
  • 收稿日期:2016-02-12 修回日期:2016-03-15 出版日期:2016-07-19 发布日期:2016-03-23
  • 通讯作者: Tel.: +1-(848)-445-6369/8, Fax: +1-(732)-445 3134, E-mail: kongt@pharmacy.rutgers.edu
  • 基金资助:

    R01 CA118947, R01 CA152826 from National Cancer Institute (NCI), R01AT007065 from the National Center for Complementary and Alternative Medicines (NCCAM), the Office of Dietary Supplements (ODS), and the National Institute of Health Grant R01 CA073674.

Development and validation of a rapid UPLC/MS method for the simultaneous determination of I3C, DIM, and related metabolites and its application to pharmacokinetics studies

Yury Gomez1, Hu Wang1, Ah-Ng Tony Kong2*   

  1. 1. Graduate Program in Pharmaceutical Science, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854
    2. Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854
  • Received:2016-02-12 Revised:2016-03-15 Online:2016-07-19 Published:2016-03-23
  • Contact: Tel.: +1-(848)-445-6369/8, Fax: +1-(732)-445 3134, E-mail: kongt@pharmacy.rutgers.edu
  • Supported by:

    R01 CA118947, R01 CA152826 from National Cancer Institute (NCI), R01AT007065 from the National Center for Complementary and Alternative Medicines (NCCAM), the Office of Dietary Supplements (ODS), and the National Institute of Health Grant R01 CA073674.

摘要:

Indole-3-carbinol (I3C) and diindolylmethane (DIM) are naturally derived dietary phytochemicals with promising anti-cancer properties that have been demonstrated both in vitro and in vivo. Using reversed-phase ultra-performance liquid chromatography(UPLC) coupled with mass spectrometry (MS), a rapid, specific, and high throughput method was developed and validated for the quantification and identification of I3C, DIM, and other I3C metabolites in plasma. Samples containing I3C or DIM and the internal standard 4-methoxy indole (IS) were extracted using a liquid-liquid extraction technique. The mean recovery was 96.21% for I3C and 108.5% for DIM. Separation was achieved using a Waters Acquity UPLC HSS T3, 1.8 µm, 2.1 mm×150 mm column and acetonitrile–water gradient elution. The flow rate was 0.3 mL/min and the run time was 9 min. The limits of detection and quantification for I3C and DIM were 15 ng/mL and 25 ng/mL, respectively. Calibration curves for I3C and DIM were linear (r2>0.99) over a concentration range of 0.025–20 µg/mL. Precision, accuracy, and stability analysis fulfilled the CDER guidelines criteria. The method was successfully applied to the determination of the pharmacokinetic parameters of I3C or DIM after oral, intravenous, or intraperitoneal administration to Sprague Dawley rats. The method described here is superior over existing analytical methods for I3C and its metabolites in terms of sensitivity, speed, and separation.

关键词: UPLC/MS, Indole-3-Carbinol, Diindolylmethane, Pharmacokinetics, Single-dose administration, Sprague-Dawley Rats

Abstract:

Indole-3-carbinol (I3C) and diindolylmethane (DIM) are naturally derived dietary phytochemicals with promising anti-cancer properties that have been demonstrated both in vitro and in vivo. Using reversed-phase ultra-performance liquid chromatography(UPLC) coupled with mass spectrometry (MS), a rapid, specific, and high throughput method was developed and validated for the quantification and identification of I3C, DIM, and other I3C metabolites in plasma. Samples containing I3C or DIM and the internal standard 4-methoxy indole (IS) were extracted using a liquid-liquid extraction technique. The mean recovery was 96.21% for I3C and 108.5% for DIM. Separation was achieved using a Waters Acquity UPLC HSS T3, 1.8 µm, 2.1 mm×150 mm column and acetonitrile–water gradient elution. The flow rate was 0.3 mL/min and the run time was 9 min. The limits of detection and quantification for I3C and DIM were 15 ng/mL and 25 ng/mL, respectively. Calibration curves for I3C and DIM were linear (r2>0.99) over a concentration range of 0.025–20 µg/mL. Precision, accuracy, and stability analysis fulfilled the CDER guidelines criteria. The method was successfully applied to the determination of the pharmacokinetic parameters of I3C or DIM after oral, intravenous, or intraperitoneal administration to Sprague Dawley rats. The method described here is superior over existing analytical methods for I3C and its metabolites in terms of sensitivity, speed, and separation.

Key words: UPLC/MS, Indole-3-Carbinol, Diindolylmethane, Pharmacokinetics, Single-dose administration, Sprague-Dawley Rats

中图分类号: 

Supporting: